ResMed (RMD) Misses Q3 EPS by 2c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $188.63 +1.26%
Revenue Growth %: +13.1%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +13.1%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.37, $0.02 worse than the analyst estimate of $2.39. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.29 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- ASM International NV (ASM:NA) PT Raised to EUR1,174 at JPMorgan
- SanDisk and Micron surge as Apple confirms memory price pass-through
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
